company background image
SRAJ

Sejahteraraya Anugrahjaya IDX:SRAJ Stock Report

Last Price

Rp181.00

Market Cap

Rp2.2t

7D

-4.2%

1Y

19.9%

Updated

18 May, 2022

Data

Company Financials
SRAJ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health1/6
Dividends0/6

SRAJ Stock Overview

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia.

Sejahteraraya Anugrahjaya Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sejahteraraya Anugrahjaya
Historical stock prices
Current Share PriceRp181.00
52 Week HighRp575.00
52 Week LowRp151.00
Beta-0.47
1 Month Change-9.50%
3 Month Change-34.89%
1 Year Change19.87%
3 Year Change-19.20%
5 Year Change-12.98%
Change since IPO-9.50%

Recent News & Updates

Shareholder Returns

SRAJID HealthcareID Market
7D-4.2%2.1%-1.9%
1Y19.9%14.4%15.6%

Return vs Industry: SRAJ exceeded the ID Healthcare industry which returned 14.4% over the past year.

Return vs Market: SRAJ exceeded the ID Market which returned 15.6% over the past year.

Price Volatility

Is SRAJ's price volatile compared to industry and market?
SRAJ volatility
SRAJ Average Weekly Movement6.1%
Healthcare Industry Average Movement5.2%
Market Average Movement6.3%
10% most volatile stocks in ID Market12.0%
10% least volatile stocks in ID Market3.0%

Stable Share Price: SRAJ is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: SRAJ's weekly volatility has decreased from 13% to 6% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19912,331Grace Riadyhttps://www.mayapadahospital.com

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. It operates through two segments, Inpatient Including Its Supporting Facilities; and Outpatient Including Its Supporting Facilities. The company operates and manages hospitals under the Mayapada Hospital name.

Sejahteraraya Anugrahjaya Fundamentals Summary

How do Sejahteraraya Anugrahjaya's earnings and revenue compare to its market cap?
SRAJ fundamental statistics
Market CapRp2.17t
Earnings (TTM)Rp165.31b
Revenue (TTM)Rp1.92t

13.1x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SRAJ income statement (TTM)
RevenueRp1.92t
Cost of RevenueRp1.25t
Gross ProfitRp677.56b
Other ExpensesRp512.26b
EarningsRp165.31b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)13.77
Gross Margin35.21%
Net Profit Margin8.59%
Debt/Equity Ratio122.5%

How did SRAJ perform over the long term?

See historical performance and comparison

Valuation

Is Sejahteraraya Anugrahjaya undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


13.14x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SRAJ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SRAJ's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: SRAJ is good value based on its PE Ratio (13.1x) compared to the ID Healthcare industry average (20.2x).

PE vs Market: SRAJ is good value based on its PE Ratio (13.1x) compared to the ID market (18.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SRAJ's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SRAJ is good value based on its PB Ratio (1.1x) compared to the ID Healthcare industry average (1.9x).


Future Growth

How is Sejahteraraya Anugrahjaya forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.1%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sejahteraraya Anugrahjaya has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Sejahteraraya Anugrahjaya performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


47.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SRAJ has high quality earnings.

Growing Profit Margin: SRAJ became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: SRAJ has become profitable over the past 5 years, growing earnings by 47% per year.

Accelerating Growth: SRAJ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SRAJ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (121.6%).


Return on Equity

High ROE: SRAJ's Return on Equity (8.6%) is considered low.


Financial Health

How is Sejahteraraya Anugrahjaya's financial position?

Financial Health Score

1/6

Financial Health Score 1/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SRAJ's short term assets (IDR1,021.5B) do not cover its short term liabilities (IDR2,659.2B).

Long Term Liabilities: SRAJ's short term assets (IDR1,021.5B) exceed its long term liabilities (IDR285.2B).


Debt to Equity History and Analysis

Debt Level: SRAJ's net debt to equity ratio (86.1%) is considered high.

Reducing Debt: SRAJ's debt to equity ratio has increased from 25.5% to 122.5% over the past 5 years.

Debt Coverage: SRAJ's debt is not well covered by operating cash flow (14.3%).

Interest Coverage: SRAJ's interest payments on its debt are not well covered by EBIT (2.6x coverage).


Balance Sheet


Dividend

What is Sejahteraraya Anugrahjaya current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SRAJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SRAJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SRAJ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SRAJ's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SRAJ has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.0yrs

Average management tenure


CEO

Grace Riady (45 yo)

10yrs

Tenure

Ms. Grace Dewi Riady has been President Commissioner of PT Maha Properti Indonesia Tbk (formerly known as PT Propertindo Mulia Investama Tbk) since May 18, 2018. Ms. Riady has been the President Director o...


Leadership Team

Experienced Management: SRAJ's management team is seasoned and experienced (10 years average tenure).


Board Members

Experienced Board: SRAJ's board of directors are seasoned and experienced ( 10 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Sejahteraraya Anugrahjaya Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Sejahteraraya Anugrahjaya Tbk
  • Ticker: SRAJ
  • Exchange: IDX
  • Founded: 1991
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: Rp2.172t
  • Shares outstanding: 12.00b
  • Website: https://www.mayapadahospital.com

Number of Employees


Location

  • PT Sejahteraraya Anugrahjaya Tbk
  • Jalan Honoris Raya Kav. 6
  • Kota Modern (Modernland)
  • Tangerang
  • Banten
  • 15117
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/18 00:00
End of Day Share Price2022/05/17 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.